US 8420799
Therapeutic compositions
granted A61KA61K31/713A61K47/554
Quick answer
US patent 8420799 (Therapeutic compositions) held by Alnylam Pharmaceuticals, Inc. expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/713, A61K47/554, A61P, A61P3/10